Authors related its activity with the progression to NASH, since the interaction of RUNX1 and C-C motif chemokine 2 (CCL2), an important adhesion molecule, mediates the infiltration of pro-inflammatory and pro-angiogenic factors in NASH [20]. Here, RUNX1 is linked to metabolic dysfunction-associated steatohepatitis.